Location History:
- Walton-on-Thames, GB (2013)
- Surrey, GB (2014)
- Sutton, GB (2017 - 2023)
Company Filing History:
6 out of 263 
3 out of 123 
3 out of 51 
Years Active: 2013-2023
Title: Michelle Dawn Garrett: Innovator in Therapeutic Compounds
Introduction
Michelle Dawn Garrett is a prominent inventor based in Walton-on-Thames, GB. She has made significant contributions to the field of therapeutic compounds, holding a total of six patents. Her work primarily focuses on innovative solutions for treating diseases, particularly those related to cancer.
Latest Patents
One of her latest patents is titled "5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof." This invention pertains to compounds that inhibit Checkpoint Kinase 1 (CHK1) kinase function. The patent outlines the pharmaceutical compositions comprising these compounds and their applications in both in vitro and in vivo settings. The compounds are designed to treat various proliferative conditions, including cancer, and can be used in combination with other therapeutic agents.
Career Highlights
Throughout her career, Michelle has worked with notable organizations such as Cancer Research Technology Limited and Astex Therapeutics Limited. Her experience in these companies has allowed her to develop and refine her innovative ideas in therapeutic research.
Collaborations
Some of her coworkers include Ian James Collins and Robert George Boyle, who have contributed to her research endeavors.
Conclusion
Michelle Dawn Garrett is a trailblazer in the field of therapeutic compounds, with a focus on innovative treatments for cancer. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.